Effect of microRNA-223 on proliferation and migration of pancreatic cancer cell lines PANC-1 and miaPaCa-2
Cheng Huang, Longhui Xiong, Yumin Xu, Ke Hu, Guangnian Ma, Xinbing Chen, Dawei Liu, De He
Abstract
Cheng Huang, Longhui Xiong, Yumin Xu, Ke Hu, Guangnian Ma, Xinbing Chen, Dawei Liu, De He
Abstract
Objective To identify the effects of microRNA (miRNA, miR)-223 on proliferation and migration of pancreatic cancer cells. Methods miR-223 mimic and inhibitor were transfected into PANC-1 and miaPaCa-2 cell lines. The expression level of miR-223 was determined by real-time fluorescent quantitative polymerase chain reaction (FQ-PCR). Cell proliferation was evaluated by methyl thiazol tetrazolium (MTT) assay. Transwell migration assy was performed for cell migration ability. Results The expression of miR-223 in the PANC-1 and miaPaCa-2 cell lines was significantly higher than that in normal pancreatic cells (8.21±0.83, 11.22±0.72, tPANC-1=14.886, P=0.000; tmiaPaCa-2=24.025, P=0.000). FQ-PCR showed the miR-223 expression level in PANC-1 and miaPaCa-2 cell lines were increased significantly after transfection with miR-223 mimics (8.18±0.82, 10.51±0.79, tPANC-1=15.221, P=0.001; tmiaPaCa-2=20.765, P=0.001). The number of pancreatic cancer cells in miR-223 tranfected group was extremely increased as compared with control group (1.43±0.07 vs. 0.49±0.08, t=15.715, P=0.000; 1.55±0.07 vs. 0.63±0.05, t=19.283, P=0.000). The number of migrated PANC-1 and miaPaCa-2 cells in miR-223 tranfected group was significantly greater than that in miR-23 control group (164.20±8.45 vs. 73.50±4.50, t=16.419, P=0.000; 133.45±7.75 vs. 56.40±6.25, t=13.401, P=0.000). The proliferation of pancreatic cancer was significantly decreased in miR-223 inhibitor transfected group as compared with that in miR-23 control group (0.73±0.06 vs. 1.04±0.05, t=6.754, P=0.000; 0.77±0.04 vs. 1.13±0.08, t=7.321, P=0.000). Transell results showed less cells in miR-223 inhibitor transfected group than in control group (35.30±3.36 vs. 72.60±4.10, t=16.419, P=0.000; 32.50±2.75 vs. 57.40±3.35, t=9.953, P=0.000). Conclusion The overexpression of miR-223 could remarkably promote the proliferation and migration abilities of human pancreatic cancer PANC-1 and miaPaCa-2 cells. Key words: MicroRNA-223; Pancratic cancer; Proliferation; Migration
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To identify the effects of microRNA (miRNA, miR)-223 on proliferation and migration of pancreatic cancer cells. Methods miR-223 mimic and inhibitor were transfected into PANC-1 and miaPaCa-2 cell lines. The expression level of miR-223 was determined by real-time fluorescent quantitative polymerase chain reaction (FQ-PCR). Cell proliferation was evaluated by methyl thiazol tetrazolium (MTT) assay. Transwell migration assy was performed for cell migration ability. Results The expression of miR-223 in the PANC-1 and miaPaCa-2 cell lines was significantly higher than that in normal pancreatic cells (8.21±0.83, 11.22±0.72, tPANC-1=14.886, P=0.000; tmiaPaCa-2=24.025, P=0.000). FQ-PCR showed the miR-223 expression level in PANC-1 and miaPaCa-2 cell lines were increased significantly after transfection with miR-223 mimics (8.18±0.82, 10.51±0.79, tPANC-1=15.221, P=0.001; tmiaPaCa-2=20.765, P=0.001). The number of pancreatic cancer cells in miR-223 tranfected group was extremely increased as compared with control group (1.43±0.07 vs. 0.49±0.08, t=15.715, P=0.000; 1.55±0.07 vs. 0.63±0.05, t=19.283, P=0.000). The number of migrated PANC-1 and miaPaCa-2 cells in miR-223 tranfected group was significantly greater than that in miR-23 control group (164.20±8.45 vs. 73.50±4.50, t=16.419, P=0.000; 133.45±7.75 vs. 56.40±6.25, t=13.401, P=0.000). The proliferation of pancreatic cancer was significantly decreased in miR-223 inhibitor transfected group as compared with that in miR-23 control group (0.73±0.06 vs. 1.04±0.05, t=6.754, P=0.000; 0.77±0.04 vs. 1.13±0.08, t=7.321, P=0.000). Transell results showed less cells in miR-223 inhibitor transfected group than in control group (35.30±3.36 vs. 72.60±4.10, t=16.419, P=0.000; 32.50±2.75 vs. 57.40±3.35, t=9.953, P=0.000). Conclusion The overexpression of miR-223 could remarkably promote the proliferation and migration abilities of human pancreatic cancer PANC-1 and miaPaCa-2 cells. Key words: MicroRNA-223; Pancratic cancer; Proliferation; Migration
Key concepts: microRNA, Transfection, Pancreatic cancer, Cell growth, Chemistry, Cell culture, Molecular biology, Real-time polymerase chain reaction